RESEARCH PAPER
Blood pressure in relation to the World Health Organization AIDS clinical staging among adults living in rural Kenya
1
Department of Education and Obesity Treatment and Metabolic Disorders, Poznan University of Medical Sciences, Poznan, Poland
Submission date: 2019-07-02
Final revision date: 2019-10-12
Acceptance date: 2019-10-28
Publication date: 2020-06-28
HIV & AIDS Review 2020;19(2):93-98
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Human immunodeficiency virus (HIV) is an independent risk factor of arterial hypertension. There is a limited data on blood pressure among HIV-positive patients living in rural areas in Africa according to the clinical progress of the disease. The aim of the study was to compare blood pressure (BP) parameters among HIV-positive adults with advanced and non-advanced HIV/acquired immunodeficiency syndrome (AIDS) living in rural Kenya.
Material and methods:
In this prospective, two-center, cross-sectional study, we examined HIV-positive individuals visiting the outpatient department for a routine check-up. BP was measured by OMRON M2 Basic BP monitor (Omron, Japan) and clinical data was collected from patients’ data charts. World Health Organization AIDS clinical stage (WACS) equal to 1 was defined as non-advanced HIV, while WACS equals 2, 3, or 4 were classified as advanced HIV. Data presented as median (interquartile range).
Results:
From the total of 245 (female, 192; 78%) participants, 162 individuals presented non-advanced HIV disease, whereas 83 had advanced HIV. Both groups did not differ significantly regarding sex, age, time since HIV diagnosis, body mass index, waist circumference, use of antiretroviral treatment, nor presence of abnormal blood pressure. However, there were significant differences between patients with non-advanced HIV and advanced HIV in diastolic BP (DBP) [71 (64-77) vs. 81 (75-88); p < 0.0001], mean BP (MBP) [87 (80-94) vs. 95 (88-102); p < 0.0001], and pulse pressure (PP) [48 (42-56) vs. 43 (35-50); p < 0.0001]. A tendency, but not significant difference between study groups in systolic BP [119 (109-129) vs. 122 (114-133); p = 0.07] was observed.
Conclusions:
HIV-positive patients with advanced form of HIV disease have higher DBP, MBP, and lower PP than individuals with non-advanced HIV living in rural Kenya.
Human immunodeficiency virus (HIV) is an independent risk factor of arterial hypertension. There is a limited data on blood pressure among HIV-positive patients living in rural areas in Africa according to the clinical progress of the disease. The aim of the study was to compare blood pressure (BP) parameters among HIV-positive adults with advanced and non-advanced HIV/acquired immunodeficiency syndrome (AIDS) living in rural Kenya.
Material and methods:
In this prospective, two-center, cross-sectional study, we examined HIV-positive individuals visiting the outpatient department for a routine check-up. BP was measured by OMRON M2 Basic BP monitor (Omron, Japan) and clinical data was collected from patients’ data charts. World Health Organization AIDS clinical stage (WACS) equal to 1 was defined as non-advanced HIV, while WACS equals 2, 3, or 4 were classified as advanced HIV. Data presented as median (interquartile range).
Results:
From the total of 245 (female, 192; 78%) participants, 162 individuals presented non-advanced HIV disease, whereas 83 had advanced HIV. Both groups did not differ significantly regarding sex, age, time since HIV diagnosis, body mass index, waist circumference, use of antiretroviral treatment, nor presence of abnormal blood pressure. However, there were significant differences between patients with non-advanced HIV and advanced HIV in diastolic BP (DBP) [71 (64-77) vs. 81 (75-88); p < 0.0001], mean BP (MBP) [87 (80-94) vs. 95 (88-102); p < 0.0001], and pulse pressure (PP) [48 (42-56) vs. 43 (35-50); p < 0.0001]. A tendency, but not significant difference between study groups in systolic BP [119 (109-129) vs. 122 (114-133); p = 0.07] was observed.
Conclusions:
HIV-positive patients with advanced form of HIV disease have higher DBP, MBP, and lower PP than individuals with non-advanced HIV living in rural Kenya.
REFERENCES (25)
1.
WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva: World Health Organization; 2007.
2.
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41 (RR-17): 1-19.
4.
Lohse N, Hansen AB, Gerstoft J, Obel N. Improved survival in HIV-infected persons: consequences and perspectives. J Antimicrob Chemother 2007; 60: 461-463.
5.
Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-860.
6.
Grunfeld C, Delaney JAC, Wanke C, et al. Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS 2009; 23: 1841-1849.
7.
Hsue PY, Hunt PW, Schnell A, et al. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS 2009; 23: 1059-1067.
8.
Leite LHM, Cohen A, Boccara F. HIV infection and aortic stiffness. Arch Cardiovasc Dis 2017; 110: 495-502.
9.
Ucciferri C, Falasca K, Vecchiet J. Hypertension in HIV: management and treatment. AIDS Rev 2017; 19: 198-211.
10.
Demir OM, Candilio L, Fuster D, et al. Cardiovascular disease burden among human immunodeficiency virus-infected individuals. Int J Cardiol 2018; 265: 195-203.
11.
Kaplan RC, Kingsley LA, Gange SJ, et al. Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS 2008; 22: 1615-1624.
12.
Lichtenstein KA, Armon C, Buchacz K, et al. Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. Clin Infect Dis 2010; 51: 435-447.
13.
Nduka CU, Stranges S, Sarki AM, Kimani PK, Uthman OA. Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysis. J Hum Hypertens 2016; 30: 355-362.
14.
Dzudie A, Rayner B, Ojji D, et al. Roadmap to achieve 25% hypertension control in Africa by 2025. Glob Heart 2018; 13: 45-59.
15.
National AIDS and STI Control Programme, Ministry of Public Health and Sanitation, Kenya. Guidelines for HIV Testing and Counselling and Kenya. Nairobi: NASCOP; 2008.
16.
Coleman A, Freeman P, Steel S, Shennan A. Validation of the Omron MX3 Plus oscillometric blood pressure monitoring device according to the European Society of Hypertension international protocol. Blood Press Monit 2005; 10: 165-168.
18.
Cywinski J, Tardieu B, Heiss HW. Essentials in pressure monitoring blood and other fluids. Clin Cardiol 1982; 5: 446-A36.
19.
Wickham H. ggplot2: elegant graphics for data analysis. 2 ed. Cham: Springer; 2016.
20.
Njelekela M, Muhihi A, Aveika A, et al. Prevalence of hypertension and its associated risk factors among 34,111 HAART naïve HIV-infected adults in Dar es Salaam, Tanzania. Int J Hypertens 2016; 2016: 5958382.
21.
Bloomfield GS, Hogan JW, Keter A, et al. Blood pressure level impacts risk of death among HIV seropositive adults in Kenya: a retrospective analysis of electronic health records. BMC Infect Dis 2014; 14: 284.
22.
Ilovi CS, Lule GN, Obel AO, Irimu HM. Correlation of WHO clinical staging with CD4 counts in adult HIV/AIDS patients at Kenyatta National Hospital, Nairobi. East Afr Med J 2011; 88: 65-70.
23.
Manner IW, Trøseid M, Oektedalen O, Baekken M, Os I. Low nadir CD4 cell count predicts sustained hypertension in HIV-infected individuals: nadir CD4 predicts hypertension in HIV. J Clin Hypertens 2013; 15: 101-106.
24.
Browning LM, Mugridge O, Chatfield MD, et al. Validity of a new abdominal bioelectrical impedance device to measure abdominal and visceral fat: comparison with MRI. Obesity (Silver Spring) 2010; 18: 2385-2391.
25.
Srinivasa S, Fitch KV, Wong K, et al. RAAS activation is associated with visceral adiposity and insulin resistance among HIV-infected patients. J Clin Endocrinol Metab 2015; 100: 2873-2882.
Share
RELATED ARTICLE
| eISSN: | 1732-2707 |
| ISSN: | 1730-1270 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
